The first published results of trials using cells derived from human embryonic stem cells appear to show they have passed an initial safety hurdle…
Day: January 23, 2012
Stem Cell Therapy Safe in Macular Degeneration (CME/CE)
(MedPage Today) — In the first application of its kind, human embryonic stem cells were safely used to treat macular degeneration in two patients, researchers reported.
NHS Choices ‘Behind the Headlines’ assessment of press reports that vitamin D ‘may stop AMD sight loss’
Source: NHS Choices
Area: News
The ‘Behind the Headlines’ service from NHS Choices has featured a quality assessment of press reports that “more vitamin D a day could keep glasses away” (reported by The Independent and others; 17th January 2012).
&…
Risk Of Blindness Halved Over Last Decade
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. A report from the University of Copenhagen and Glostrup Hospital in Denmark shows the number of new cases of blindness and severe visual loss in Denmar…
How Protein In Teardrops Annihilates Harmful Bacteria
A disease-fighting protein in our teardrops has been tethered to a tiny transistor, enabling UC Irvine scientists to discover exactly how it destroys dangerous bacteria. The research could prove critical to long-term work aimed at diagnosing cancers an…
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
Status: Active, not recruiting,
Condition Summary: Eye Diseases; Glaucoma, Open-Angle; Glaucoma